View More Recent Stories
-
Microbot Medical (MBOT) PT Raised to $9 at H.C. Wainwright
-
Microbot Medical (MBOT) Strengthens Its Commercial Capabilities with the Addition of David J. Wilson to the Board of Directors
-
Microbot Medical (MBOT) Announces 3.79M Share Offering at $2.27/sh
-
Microbot Medical (MBOT) Announces $7 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
-
Microbot Medical (MBOT) Announces FDA Submission for the Commercialization of the LIBERTY Endovascular Robotic System
-
Microbot Medical (MBOT) Announces the Successful Completion of its Pivotal Human Clinical Trial
-
Microbot Medical (MBOT) Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up
-
Microbot Medical (MBOT) Signs Phase 2 Collaboration Agreement with Corewell Health to Advance Remote Telesurgery Using the LIBERTY Endovascular Robotic System
-
Microbot Medical (MBOT) Partners with Baptist Hospital of Miami to Participate in its Trial
-
Microbot Medical (MBOT) Partners with Brigham and Women's Hospital for Human Clinical Trial
-
Microbot Medical (MBOT) Files for 3.21M Share Offering by Selling Stockholders
